Category:
Prophylactic Biological Products
CAS NO:
737789-87-6
Standard:
In-house Standards,
Relugolix is a gonadotropin-releasing hormone (GnRH) receptor
antagonist indicated for the treatment of adult patients with advanced prostate cancer.
Relugolix is an oral small-molecule GnRH receptor antagonist used in hormone-sensitive conditions. Its synthesis involves complex organic coupling with a molecular formula of C29H37N5O6 and CAS number 1248320-14-2.
Strictly monitor bone mineral density during long-term use. Store in controlled room temperature (20°C–25°C) away from moisture to maintain chemical stability.